Global CGM (Continuous Blood Glucose Monitoring) Systems Market – Industry Analysis, Size, Share, Trends and Forecast, 2016 – 2022


Select Your License Type


samplerequest
makeanenquiry
download
Discount



                                   Figure : Global CGM (Continuous Blood Glucose Monitoring) Systems Market


The market for global continuous blood glucose monitoring (CGM) systems was valued at around USD 0.7 billion in 2015 and is expected to reach USD 3.3 billion by 2022, growing at a CAGR of around 24.4% during the forecast period of 2016 to 2022. During the last four decades, there have been a continuous advances in the field of glucose monitoring, which have led to the development of highly evolved blood glucose meters, include non-invasive glucose monitoring (NGM) devices and continuous blood glucose monitoring systems (CGM). Glucose monitoring is an integral part of diabetes management, and the maintenance of physiological blood glucose concentration is the only way for a diabetic to avoid life-threatening diabetic complications. CGM systems have led to tremendous improvements in diabetic management, as shown by the significant lowering of glycated hemoglobin (HbA1c) in adults with type I diabetes. Most of the CGMS have been minimally-invasive, although the more recent ones are based on NGM techniques.

Diabetes disease is growing across the globe at an extraordinary pace and has become a serious health issue during the last two decades. It is a major cause of mortality in the age group of 20–79 years. Based on its rapidly increasing incidence, it has been declared a global epidemic by the World Health Organization (WHO). According to the International Diabetes Federation (IDF), the number of diabetic patients reached 415 million in 2015 globally and is expected to reach around 642 million by 2040.  According to the IDF, global healthcare expenditures to treat diabetes and its complications was USD 673 billion in 2015, representing 12% of total global healthcare expenditures and is expected to exceed USD 802 billion by 2040.

Rise in base of geriatric population, increasing incidence rates of diabetes worldwide, benefits of CBGM devices over blood glucometers such as reports generation and access for historic blood glucose data to analyze the trend, growing awareness among the population, increasing preference for non-invasive methods, and approval of artificial pancreas from FDI are expected to drive the market at a significant growth rate in the coming years. However, stringent regulatory approvals and high costs associated with these devices are some of the restraining factors which could hinder the market.

Geographically, North America is the leading contributor to the market and is expected to retain its position during the forecast period due to the presence of large number of geriatric population and large base of population with high purchasing power. However, Asia-Pacific market is expected to grow at a faster rate during the forecast period. This is predominantly due to increased healthcare awareness, improved economic growth, increasing number of obesity cases and growing awareness among the population about non-invasive glucose monitoring systems.

Report Highlights:

The report delivers a strategic analysis of the global market for continuous glucose monitoring systems and growth forecast for the period from 2016 – 2022. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type of component. It also covers geographical analysis of the market with growth forecast for the period of 2016 – 2022. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.

Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global continuous glucose monitoring systems market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies

Companies profiled:

  • Dexcom
  • Medtronic
  • Abbott
  • C8 Medisensors
  • Integrity Applications Ltd.
  • OrSense Ltd.
  • Echo Therapeutics Inc.
  • Novo Nordisk, etc.

1.Scope of the report

1.1 Report description
1.2 Research methodology
1.3 List of abbreviations
1.4 Market segmentation

2 Executive summary
3 Qualitative analysis

3.1 Market overview

3.1.1 Drivers
3.1.2 Restraints

3.2 Porters five forces analysis
3.3 Cost comparison of CGM products
3.4 Market share analysis of key players, 2015
3.5 Competitive matrix of the key companies

4 Global CGM systems market, by component, 2015 – 2022

4.1 The CGM monitor
4.2 The CGM Transmitter
4.3 The glucose sensor

5 Global CGM systems market, by geography, 2015 – 2022

5.1 North America

5.1.1 The CGM monitor
5.1.2 The CGM Transmitter
5.1.3 The glucose sensor

5.2 Europe

5.2.1 The CGM monitor
5.2.2 The CGM Transmitter
5.2.3 The glucose sensor

5.3 APAC

5.3.1 The CGM monitor
5.3.2 The CGM Transmitter
5.3.3 The glucose sensor

5.4 Rest of the World

5.4.1 The CGM monitor
5.4.2 The CGM Transmitter
5.4.3 The glucose sensor

6 Company profiles

6.1 Dexcom
6.2 Medtronic
6.3 Abbott
6.4 C8 Medisensors
6.5 Integrity Applications Ltd
6.6 Echo Therapeutics Inc.
6.7 Novo Nordisk
6.8 OrSense Ltd.


Got a Question?

If you have a question to ask our analyst, just fill this form and send it across, our representative will get in touch with you shortly.